Triptolide inhibits human immunodeficiency virus type 1 replication by promoting proteasomal degradation of Tat protein

被引:0
作者
Zhitao Wan
Xulin Chen
机构
[1] Wuhan Institute of Virology,State Key Laboratory of Virology
[2] Chinese Academy of Sciences,undefined
[3] China Novartis Institutes for BioMedical Research,undefined
来源
Retrovirology | / 11卷
关键词
HIV-1; Triptolide; Antiviral; Tat; Proteasomal degradation;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 228 条
  • [1] Volberding PA(2010)Antiretroviral therapy and management of HIV infection Lancet 376 49-62
  • [2] Deeks SG(2000)Adverse effects of antiretroviral therapy Lancet 356 1423-1430
  • [3] Carr A(2008)The spread, treatment, and prevention of HIV-1: evolution of a global pandemic J Clin Invest 118 1244-1254
  • [4] Cooper DA(2004)Adverse effects of antiretroviral therapy for HIV infection Can Med Assoc J 170 229-238
  • [5] Cohen MS(2000)Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy Annu Rev Immunol 18 665-708
  • [6] Hellmann N(1991)Regulation of HIV-1 gene expression FASEB J 5 2361-2368
  • [7] Levy JA(2005)A new paradigm in eukaryotic biology: HIV Tat and the control of transcriptional elongation PLoS Biol 3 e76-254
  • [8] DeCock K(1999)Tackling tat J Mol Biol 293 235-462
  • [9] Lange J(1998)A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA Cell 92 451-2632
  • [10] Montessori V(1997)Transcription elongation factor P-TEFb is required for HIV-1 Tat transactivation in vitro Genes Dev 11 2622-2634